OBJECTIVE: Although there is a growing national focus on health care cost containment and accountability in resource utilization, childhood cancer therapy costs continue to increase without proportionate survival improvements. Economic evaluations (EEs) such as cost and/or cost effectiveness analysis may identify areas to improve resource efficiency. This review aims to identify and characterize the EE studies performed in this field. METHODS: We performed a structured literature search of the Medline, PubMed, and the National Health Service EE databases from 2000 to 2011. Concepts for the search included "cost analyses," "child," and "cancer." Studies were limited to original research, comparison of 2 or more treatments using monetary units, English language, and originating from economically developed countries. Identified studies were assessed by the Drummond checklist and characterized by the therapy studied, data sources, and research perspectives. RESULTS: Forty studies met inclusion criteria. Eleven studied chemotherapy, surgery, or radiation. Twenty-nine studied supportive measures such as growth factor support or treatment of infection. The median Drummond score was 6 of 10 (range, 2-9). Only 15 (36%) included treatment outcomes when comparing costs. Methodological limitations were common. CONCLUSIONS: A wide variety of topics and methodological limitations made comparisons between studies difficult. Strategies for increasing the generalizability of future EE studies are presented. Substantial opportunity exists for EE research in childhood cancer.
OBJECTIVE: Although there is a growing national focus on health care cost containment and accountability in resource utilization, childhood cancer therapy costs continue to increase without proportionate survival improvements. Economic evaluations (EEs) such as cost and/or cost effectiveness analysis may identify areas to improve resource efficiency. This review aims to identify and characterize the EE studies performed in this field. METHODS: We performed a structured literature search of the Medline, PubMed, and the National Health Service EE databases from 2000 to 2011. Concepts for the search included "cost analyses," "child," and "cancer." Studies were limited to original research, comparison of 2 or more treatments using monetary units, English language, and originating from economically developed countries. Identified studies were assessed by the Drummond checklist and characterized by the therapy studied, data sources, and research perspectives. RESULTS: Forty studies met inclusion criteria. Eleven studied chemotherapy, surgery, or radiation. Twenty-nine studied supportive measures such as growth factor support or treatment of infection. The median Drummond score was 6 of 10 (range, 2-9). Only 15 (36%) included treatment outcomes when comparing costs. Methodological limitations were common. CONCLUSIONS: A wide variety of topics and methodological limitations made comparisons between studies difficult. Strategies for increasing the generalizability of future EE studies are presented. Substantial opportunity exists for EE research in childhood cancer.
Authors: Kathleen A Meeske; Lingyun Ji; David R Freyer; Paul Gaynon; Kathleen Ruccione; Anna Butturini; Vassilios I Avramis; Stuart Siegel; Yousif Matloub; Nita L Seibel; Richard Sposto Journal: Pediatr Blood Cancer Date: 2015-07-14 Impact factor: 3.167
Authors: Sapna Kaul; Bree Barbeau; Jennifer Wright; Mark Fluchel; Anne C Kirchhoff; Richard E Nelson Journal: J Oncol Pract Date: 2015-06-23 Impact factor: 3.840
Authors: Kelly D Getz; Yimei Li; Todd A Alonzo; Matthew Hall; Robert B Gerbing; Lillian Sung; Yuan-Shung Huang; Staci Arnold; Alix E Seif; Tamara P Miller; Rochelle Bagatell; Brian T Fisher; Peter C Adamson; Alan Gamis; Ron Keren; Richard Aplenc Journal: Pediatr Blood Cancer Date: 2015-05-06 Impact factor: 3.167
Authors: Gina E Nam; Sapna Kaul; Yelena P Wu; Richard E Nelson; Jennifer Wright; Mark N Fluchel; Claire C Hacking; Anne C Kirchhoff Journal: J Cancer Surviv Date: 2015-01-10 Impact factor: 4.442
Authors: Heidi V Russell; Yueh-Yun Chi; M Fatih Okcu; M Brooke Bernhardt; Carlos Rodriguez-Galindo; Abha A Gupta; Douglas S Hawkins Journal: Cancer Date: 2021-10-08 Impact factor: 6.860
Authors: Mary Puckett; Antonio Neri; Elizabeth Rohan; Castine Clerkin; J Michael Underwood; A Blythe Ryerson; Sherri L Stewart Journal: Public Health Rep Date: 2016 Jan-Feb Impact factor: 2.792